Product Information

ACITRETIN 10 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.3225 per EA under NDC 00093113556. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Apr 4, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACITRETIN 10 MG CAPSULE

Acitretin
$2.3225per EA

Strength

10 mg/1

NDC

00093113556

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ACITRETIN

Approval Type

Generic (ANDA)

FDA Application

ANDA091455

FDA Approved

4/4/2013

TE Code

AB

On Market Since

7/19/2013

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ACITRETIN 10 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 89.0%. The table below summarizes its recorded NADAC range and movement.

Current price$2.3225 per EA
All-time high$22.8882 (Dec 10, 2014)
All-time low$2.1155 (May 20, 2026)
52-week high$4.4078
52-week low$2.1155
Median price$8.6989
Average price$10.9965
Largest weekly change+103.6% (Mar 18, 2020)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+7.1%

1M

+8.7%

3M

+9.8%

6M

-6.3%

1Y

-44.8%

3Y

-62.5%

5Y

-65.6%

All

-89.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ACITRETIN 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 10 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $2.3225 per EA (NDC 00093113556), effective Aug 19, 2026.

How has the price of ACITRETIN 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ACITRETIN 10 MG CAPSULE has declined 89.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACITRETIN 10 MG CAPSULE?

Since Nov 28, 2013, the NADAC for ACITRETIN 10 MG CAPSULE has ranged from a low of $2.1155 (May 20, 2026) to a high of $22.8882 (Dec 10, 2014), with a median of $8.6989 per EA.

Are there cheaper alternatives to ACITRETIN 10 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACITRETIN 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures ACITRETIN 10 MG CAPSULE?

ACITRETIN 10 MG CAPSULE (NDC 00093113556) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.